CORTCorcept Therapeutics Incorporated

$119.82

What is the market doing?

What the tape says about CORT

Corcept Therapeutics Incorporated is +68% over the past year while the S&P 500 is +23%: 45 points ahead of the market.

+68%

1-year return · S&P 500 +23%

vs 200-day average
+87%

vs 200-day average · a clear uptrend

RSI (14)
72

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
−3.0%

Below its 52-week high

2024-08-06$27.08 – $123.53 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$119.82
1 monthS&P 500 +3.7%
+24%
1 yearS&P 500 +23%
+68%
5 yearsS&P 500 +87%
+470%
vs 50-day average$95.07
+26%
52-week high
$123.53
52-week low
$32.15
Annualised volatility
102%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
$1.3M
Calendar-year price return
YearReturn
2026 (year to date)+244%
2025−31%
2024+55%
2023+60%
2022+2.6%
2021−24%
2020+116%
2019−9.4%
2018−26%
2017+149%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan106 of 10+4.2%
Feb104 of 10−0.61%
Mar107 of 10+13%
Apr105 of 10−3.3%
May107 of 10+11%
Jun107 of 10+4.9%
Jul117 of 11+3.3%
Aug117 of 11+7.3%
Sep106 of 10+11%
Oct106 of 10−0.76%
Nov106 of 10+7.5%
Dec103 of 10−7.4%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.